Sunday, 27 September 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Earnings Call

Dr. Agarwals Health Care Earnings Call: Key Takeaways

Dr. Agarwal’s reported strong FY26 performance, crossing INR 2,000cr revenue milestone with significant network expansion and EBITDA margin improvement to 28.9%.

Why this was an Alfa AlertNot a filter event. Performance met stated guidance; no material 10% beat over own guidance was confirmed.
Highlights
Revenue growthFY26 revenue up 21.6% YoY; Q4 up 22.6%.
MarginsEBITDA margins improved 31bps to 28.9% in FY26.
Demand visibilityStrong; footfalls up 25% to 10,000 patients daily.
Management confidenceHigh; citing disciplined execution and successful greenfield engine scaling.

Growth

FY26 Revenue rose 21.6% to ₹2,080cr; PAT surged 52.4% to ₹168cr with 7.9% margins.

Outlook

Guidance to commission 60 new facilities in FY27; ₹380-400cr planned capex; targeting Mumbai and North regions.

Risks

Challenges in real estate acquisition and regulatory compliance delays for new facility openings.

Source

Earnings Call filed with BSE, NSE: AGARWALEYE. Summary written with AI assistance from the document.

Read the document ↗

Dr. Agarwals Health Care Ltd: key numbers

Share price
₹500.00
Market cap
₹15,851 Cr
Revenue (annual)
₹2,080 Cr
Net profit (annual)
₹133.2 Cr
P/E (TTM)
106.8×Sector 57.8×
Promoter holding
32.34%-0.02% QoQ
FII holding
57.97%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Dr. Agarwals Health Care Ltd

All →
18:50 IST NSE
Annual General Meeting

Dr. Agarwals Health Care Annual General Meeting

Dr. Agarwal's Health Care Limited held its 16th AGM on September 21, 2026. Shareholders approved all agenda items, including financial statements and director re-appointments.